Profusa, Inc. Common Stock (PFSA) Stock
Fundamentals
Technicals
Analyst Ratings
Financials
Performance
No data available
Debt & Balance Sheet
No data available
Revenue to Profit
No data available
Earnings
No data available
% positive news of 1 articles
published over the past 14 days
About Profusa, Inc. Common Stock
Profusa Inc is a clinical-stage digital health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients with a variety of different diseases and conditions. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Chung-Bin Hwang Ph.D. | President | 1968 |
| Mr. Fred S. Knechtel | Chief Financial Officer | 1961 |
| Mr. Jack E. Stover CPA | CEO & Executive Chairman | 1953 |
| Mr. William McMillan | Co-founder, Chief Scientific Officer & Head of Research | 1951 |
| Mr. David Icke | Head of Digital Health Business | — |
| Mr. Sean Givens | Head of Government Business | — |
Fundamentals
Valuation
Earnings Per Share
Income Statement
Dividend
Solvency
Technicals
What the experts say
0 Wall Street Analyst Ratings
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -65.3 | -30.1 | -21.4 | -22.4 | -11.0 | -34.2 | ||||||
| 2026 | -7.3 | -84.4 | -48.1 | +3.0 | -36.9 | -66.0 | -67.4 | -22.1 | -24.3 |
Corporate actions
Upcoming
No upcoming corporate actions for PFSA




